Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
1376
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.92M | 0.01% |
208,850
-57,800
| -22% | -$1.72M |
|
1377
Gencor Industries
GENC
$209M
| $5.92M | 0.01% |
385,140
-17,700
| -4% | -$222K |
|
1378
Pitney Bowes
PBI
$2.4B
| $5.92M | 0.01% |
1,521,071
+376,721
| +33% | +$1.58M |
|
|
GOGL
1379
DELISTED
Golden Ocean Group
GOGL
| $5.91M | 0.01% |
620,869
-1,150,322
| -65% | -$10.9M |
|
|
GLDD
1380
DELISTED
Great Lakes Dredge & Dock
GLDD
| $5.89M | 0.01% |
1,085,501
-174,034
| -14% | -$1.04M |
|
|
SFIX
1381
Stitch Fix
SFIX
$536M
| $5.88M | 0.01% |
1,151,400
-1,373,400
| -54% | -$6.43M |
|
|
CCRD
1382
DELISTED
CoreCard
CCRD
| $5.86M | 0.01% |
194,596
-23,101
| -11% | -$737K |
|
1383
Kinetik
KNTK
$3.72B
| $5.84M | 0.01% |
186,562
-28,500
| -13% | -$874K |
|
1384
Conduent
CNDT
$244M
| $5.83M | 0.01% |
1,701,100
+86,900
| +5% | +$357K |
|
1385
BCE
BCE
$20.2B
| $5.83M | 0.01% |
130,198
-601,760
| -82% | -$27.2M |
|
1386
J&J Snack Foods
JJSF
$1.43B
| $5.82M | 0.01% |
39,256
-20,150
| -34% | -$2.92M |
|
1387
MillerKnoll
MLKN
$1.53B
| $5.82M | 0.01% |
284,483
-29,100
| -9% | -$654K |
|
1388
Alpha and Omega Semiconductor
AOSL
$950M
| $5.8M | 0.01% |
215,400
-61,200
| -22% | -$1.78M |
|
1389
Clover Health Investments
CLOV
$2.2B
| $5.79M | 0.01% |
6,848,400
+2,446,000
| +56% | +$2.68M |
|
1390
Adient
ADNT
$1.65B
| $5.78M | 0.01% |
+141,100
| New | +$5.89M |
|
|
CVSA
1391
Covista Inc
CVSA
$4.25B
| $5.77M | 0.01% |
149,400
+74,300
| +99% | +$2.84M |
|
|
RNAM
1392
DELISTED
Avidity Biosciences
RNAM
| $5.76M | 0.01% |
375,100
+208,500
| +125% | +$4.59M |
|
1393
Hubbell
HUBB
$25B
| $5.74M | 0.01% |
23,600
+4,100
| +21% | +$981K |
|
1394
Jakks Pacific
JAKK
$301M
| $5.72M | 0.01% |
330,818
+51,624
| +18% | +$968K |
|
1395
Regional Management Corp
RM
$301M
| $5.72M | 0.01% |
219,237
-3,900
| -2% | -$121K |
|
1396
Kornit Digital
KRNT
$705M
| $5.72M | 0.01% |
295,413
-49,087
| -14% | -$1.11M |
|
1397
Albany International
AIN
$2.11B
| $5.69M | 0.01% |
63,700
+2,000
| +3% | +$202K |
|
|
SGMO
1398
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $5.69M | 0.01% |
3,232,795
+1,113,299
| +53% | +$3.18M |
|
|
MGIC
1399
DELISTED
Magic Software Enterprises
MGIC
| $5.67M | 0.01% |
416,064
+28,400
| +7% | +$432K |
|
1400
Puma Biotechnology
PBYI
$404M
| $5.67M | 0.01% |
1,834,913
+136,070
| +8% | +$513K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.